Additional file 3: Figure S3. of Distinct activity of the bone-targeted gallium compound KP46 against osteosarcoma cells - synergism with autophagy inhibition

Kubista, Bernd; Schoefl, Thomas; Mayr, Lisa; van Schoonhoven, Sushilla; Heffeter, Petra; Windhager, Reinhard; Keppler, Bernhard; Berger, Walter

doi:10.6084/m9.figshare.c.3741158_D3.v1

13046_2017_527_MOESM3_ESM.pdf (160.62 kB)

Additional file 3: Figure S3. of Distinct activity of the bone-targeted gallium compound KP46 against osteosarcoma cells - synergism with autophagy inhibition

journal contribution

posted on 2017-04-12, 05:00 authored by Bernd Kubista, Thomas Schoefl, Lisa Mayr, Sushilla van Schoonhoven, Petra Heffeter, Reinhard Windhager, Bernhard Keppler, Walter Berger

KP46 treatment synergizes with the autophagy inhibitor chloroquine. Cell viability after combined treatment of OS cells with KP46 and chloroquine for 72Â h at the indicated concentrations was determined by MTT survival assay. CI values for HOS and SAOS-2 cells derived from two independent experiments in triplicate are shown representatively. The respective growth curves are shown in Fig.Â 5d. (PDF 160Â kb)

Funding

medical research fund of the Major of the City of Vienna

History

Usage metrics

Keywords

Osteosarcoma KP46 Anticancer gallium compound Autophagy Obatoclax

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 3: Figure S3. of Distinct activity of the bone-targeted gallium compound KP46 against osteosarcoma cells - synergism with autophagy inhibition

Funding

medical research fund of the Major of the City of Vienna

History

Usage metrics

Categories

Keywords

Licence

Exports